A Phase 2 Study of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Diet and Exercise

NCT06411275 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

113

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: HTD1801
DRUG: Placebo
DRUG: HTD1801

Sponsor

HighTide Biopharma Pty Ltd

Collaborators

[object Object]